First Manhattan’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-94
| Closed | -$139 | – | 1035 |
|
|
2024
Q1 | $139 | Hold |
94
| – | – | ﹤0.01% | 1385 |
|
|
2023
Q4 | $102 | Hold |
94
| – | – | ﹤0.01% | 1413 |
|
|
2023
Q3 | $110 | Hold |
94
| – | – | ﹤0.01% | 1457 |
|
|
2023
Q2 | $132 | Hold |
94
| – | – | ﹤0.01% | 1398 |
|
|
2023
Q1 | $141 | Hold |
94
| – | – | ﹤0.01% | 1489 |
|
|
2022
Q4 | $109 | Hold |
94
| – | – | ﹤0.01% | 1646 |
|
|
2022
Q3 | $0 | Hold |
94
| – | – | ﹤0.01% | 1599 |
|
|
2022
Q2 | $0 | Hold |
94
| – | – | ﹤0.01% | 1621 |
|
|
2022
Q1 | $0 | Hold |
94
| – | – | ﹤0.01% | 1648 |
|
|
2021
Q4 | $0 | Hold |
94
| – | – | ﹤0.01% | 1629 |
|
|
2021
Q3 | $0 | Sell |
94
-2,000
| -96% | – | ﹤0.01% | 1638 |
|
|
2021
Q2 | $5K | Buy |
2,094
+2,000
| +2,128% | +$4.78K | ﹤0.01% | 1383 |
|
|
2021
Q1 | $0 | Hold |
94
| – | – | ﹤0.01% | 1522 |
|
|
2020
Q4 | $0 | Hold |
94
| – | – | ﹤0.01% | 1376 |
|
|
2020
Q3 | $0 | Hold |
94
| – | – | ﹤0.01% | 1398 |
|
|
2020
Q2 | $0 | Hold |
94
| – | – | ﹤0.01% | 1434 |
|
|
2020
Q1 | $0 | Hold |
94
| – | – | ﹤0.01% | 1413 |
|
|
2019
Q4 | $0 | Hold |
94
| – | – | ﹤0.01% | 1338 |
|
|
2019
Q3 | $0 | Hold |
94
| – | – | ﹤0.01% | 1369 |
|
|
2019
Q2 | $0 | Hold |
94
| – | – | ﹤0.01% | 1414 |
|
|
2019
Q1 | $0 | Buy |
+94
| New | – | ﹤0.01% | 1431 |
|